Deerfield Management Company, L.P. (Series C) Cerus Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.04 Billion
- Q4 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Cerus Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 50,305 shares of CERS stock, worth $76,966. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,305Holding current value
$76,966% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding CERS
# of Institutions
159Shares Held
146MCall Options Held
48.6KPut Options Held
8.7K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl20.8MShares$31.8 Million0.28% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$29.8 Million0.33% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$15.9 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.32MShares$12.7 Million0.06% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $271M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...